Le Lézard
Classified in: Health, Science and technology

Innovations Day Highlights Drug-free Neuromodulation Therapy


SYDNEY and SAN FRANCISCO, April 22, 2019 /PRNewswire/ -- Development of drug-free technology to treat chronic conditions will be among the discussed topics when more than 200 worldwide entrepreneurs, industry leaders, and investment professionals meet for a daylong session on "Disruptive Innovation: The Driving Force of Progress in Neuromodulation." 

The fifth Innovations Day takes place Sunday, 26 May 2019 at the International Convention Centre in Sydney, Australia, before the International Neuromodulation Society 14th World Congress.

Current developments in neuroscience and engineering accelerate emerging interventions and potential treatments, utilizing innovative neuromodulation methods, targets, frequencies, paradigms and principles.

The session intersperses presentations by emerging companies with keynote talks, and an executive panel addressing commercialization:  

Early stage:
Attila Borbáth, CEO, Co-founder, Synergia Medical
Sjaak Deckers, PhD, CEO, GTX medical BV
Song-Song Liao, Founder/Interim CEO, Aldans Health
Stephen R. Popielarski, PhD, CEO, Thermaquil
Samuel Hamner, PhD, Director of Product Innovation, Cala Health

Intermediate stage:
Jason Hannon, CEO, Mainstay "The Challenges of Disruption in Neuromodulation for Chronic Low Back Pain: Addressing Cause vs. Symptoms"
Jonathan Ruais, CCO, Nalu "The Nalu Perspective on Increasing Patient Acceptance of the Therapy"
John Parker, PhD, Founder/CEO, Saluda "How to Repurpose Your Disruption into Other Potential Fields and Applications?"
Chad Andresen, VP of Marketing, StimRelieve "How to Re-energize a Field with Multiple Failed Trials: The Occipital Challenge?"

Advanced stage:
Keith Boettiger, Abbott
Marshall Stanton, MD, Medtronic
Paul Hanchin, Nuvectra
Laura Perryman, Stimwave
Maulik Nanavaty, PhD, Boston Scientific

Keynotes:
Josh Makower, MD, General Partner, NEA "Neuromodulation Innovation and Inspiration into the Next Century"
David Putrino, PhD, Mt. Sinai "Turning Neuromodulation on its Head: Fresh Perspectives on Interacting with the Nervous System"
Renee St. Amant, PhD, Innovator of the Year, Arm Limited "Bioelectronic Medicine as a Disruptive Technology"
Georgios Matis, MD, PhD, Cologne "Rediscovery of an Often Ignored Physiologic Signal: The Potential Source of Disruptive Innovation in Neuromodulation: What Can we Learn from Social Media Disrupting our Communication Style?"
James Cavuoto, Editor/Publisher, Neurotech Reports "Disruptive Innovation in Neuromodulation: Tips and Tricks in Determining Newsworthiness of Innovations"

About the International Neuromodulation Society
The nonprofit International Neuromodulation Society presents the full breadth of neuromodulation therapies through its website, its journal Neuromodulation: Technology at the Neural Interface, regional scientific meetings, and the biennial INS World Congress.

Contact:
Nancy Garcia, INS Public Education and Website Manager
[email protected]
Messages: +1 415 683 3237

SOURCE International Neuromodulation Society


These press releases may also interest you

at 07:35
Ant International and Capital A Berhad, owner of AirAsia, have formed a strategic collaboration in various areas, exploring to integrate more local payments methods and providing payment orchestration services to Capital A's platforms, work on...

at 07:00
Palantir Technologies Inc. today announced that it was selected by the Defense Information Systems Agency (DISA) to deliver an Electromagnetic Battle Management - Joint Decision Support (EMBM-J DS) Prototype. This effort will provide the Department...

at 06:30
The Actuators market is estimated at USD 67.7 billion in 2024 and is projected to reach USD 94.8 billion by 2029, at a CAGR of 7.0 % from 2024 to 2029 according to a new report by MarketsandMarketstm. The growth can be attributed to growing...

at 06:13
JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") , one of the largest and most innovative solar module manufacturers in the world, today announced that since March 20, 2024, the Company has repurchased 788,178 American depositary shares...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:02
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major...



News published on and distributed by: